-
Journal of Blood Medicine
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Solitary plasmacytoma of the jaw
Review
(2033) Views (1076) Full article downloads
Authors: Serena Marotta, Pierpaolo Di Micco
Published Date March 2010
Volume 2010:1 Pages 33 - 36
DOI: http://dx.doi.org/10.2147/JBM.S8385
Serena Marotta1, Pierpaolo Di Micco2
1Haematology Division, Second University of Naples, Italy; 2Internal Medicina, Fatebenefratelli Hospital of Naples, Italy
Abstract: Solitary plasmacytoma may be considered as a rare neoplasm of head and neck and is a different disease compared to multiple myeloma. The main difference is related to the better clinical prognosis of solitary plasmacytoma, which may be clinically silent for several years but several local recurrences may be possible once diagnosed and treated. Clinical signs and symptoms of solitary plasmacytoma are related to bone pain and possible bone fractures. Partial local impairment of local bone function may be present. Bone swelling and local involvement of mucosa and local soft tissue may be revealed. Systemic findings related to the production of monoclonal protein are usually not present and a monoclonal spike in serum electrophoresis may be absent as the monoclonal Bence–Jones protein in the urine. Other systemic dysfunctions as systemic bone marrow involvement with related anemia and absent thrombocytopenia. However, although very rare, solitary plasmacytoma of the jaw may have several clinical presentations and here we review clinical differences reported in the literature.
Keywords: solitary plasmacytoma, multiple myeloma, monoclonal, bone function, fracture
Other articles by Dr Pierpaolo Di Micco
Etiology of hypercoagulable state in women with recurrent fetal loss without other causes of miscarriage from Southern Italy: new clinical target for antithrombotic therapy
Intima-media thickness evolution after treatment with infliximab in patients with rheumatoid arthritis
Venous thromboembolism and pregnancy
Readers of this article also read:
Critical appraisal of the role of glucosamine and chondroitin in the management of osteoarthritis of the knee
Ego mechanisms of defense are associated with patients’ preference of treatment modality independent of psychological distress in end-stage renal disease
Can a gentamicin-specific chart reduce neonatal medication errors?
Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered
Dashboards in neonatology
ABO and rhesus blood group distribution in Kurds
Anesthesiologists’ perception of patients’ anxiety under regional anesthesia
Deep vein thrombosis: a clinical review
Everolimus-eluting stents: update on current clinical studies
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- Use of sulodexide in patients with peripheral vascular disease
- Treatment of hemophilia: a review of current advances and ongoing issues
- ABO and rhesus blood group distribution in Kurds
- Deep vein thrombosis: a clinical review




